
### [NCIT:C4783](http://purl.obolibrary.org/obo/NCIT_C4783)
**Label:** Borderline Ovarian Epithelial Tumor

**Subclasses:** [NCIT:C27289](http://purl.obolibrary.org/obo/NCIT_C27289) (Borderline Ovarian Endometrioid Cystadenofibroma), [NCIT:C9459](http://purl.obolibrary.org/obo/NCIT_C9459) (Borderline Ovarian Brenner Tumor/Atypical Proliferative Ovarian Brenner Tumor), [NCIT:C5226](http://purl.obolibrary.org/obo/NCIT_C5226) (Borderline Ovarian Serous Tumor), [NCIT:C115352](http://purl.obolibrary.org/obo/NCIT_C115352) (Recurrent Borderline Ovarian Surface Epithelial-Stromal Tumor), [NCIT:C7983](http://purl.obolibrary.org/obo/NCIT_C7983) (Borderline Ovarian Endometrioid Tumor/Atypical Proliferative Ovarian Endometrioid Tumor), [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), [NCIT:C40069](http://purl.obolibrary.org/obo/NCIT_C40069) (Borderline Ovarian Endometrioid Adenofibroma), [NCIT:C7281](http://purl.obolibrary.org/obo/NCIT_C7281) (Borderline Ovarian Seromucinous Tumor/Atypical Proliferative Ovarian Seromucinous Tumor), [NCIT:C94825](http://purl.obolibrary.org/obo/NCIT_C94825) (Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor), [NCIT:C94824](http://purl.obolibrary.org/obo/NCIT_C94824) (Stage III Borderline Ovarian Surface Epithelial-Stromal Tumor), [NCIT:C94822](http://purl.obolibrary.org/obo/NCIT_C94822) (Stage II Borderline Ovarian Surface Epithelial-Stromal Tumor), [NCIT:C94821](http://purl.obolibrary.org/obo/NCIT_C94821) (Stage I Borderline Ovarian Surface Epithelial-Stromal Tumor), [NCIT:C40088](http://purl.obolibrary.org/obo/NCIT_C40088) (Borderline Ovarian Transitional Cell Tumor), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C40080](http://purl.obolibrary.org/obo/NCIT_C40080) (Borderline Ovarian Clear Cell Tumor), 

**Class expressions from DL-Learner:**

- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 55.56%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 55.56%
- Thing 52.44%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 42.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39094](http://purl.obolibrary.org/obo/NCIT_C39094) (Inhibition of Cellular Proliferation by Gleevec Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39092](http://purl.obolibrary.org/obo/NCIT_C39092) (Growth Hormone Signaling Pathway))) 40.91%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39091](http://purl.obolibrary.org/obo/NCIT_C39091) (Corticosteroid Cardioprotection Pathway))) 40.91%


